Arcus Biosciences Inc (RCUS)
17.40
+0.29
(+1.69%)
USD |
NYSE |
May 15, 15:17
Arcus Biosciences Total Liabilities (Quarterly): 586.00M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 586.00M |
December 31, 2023 | 633.00M |
September 30, 2023 | 671.00M |
June 30, 2023 | 654.00M |
March 31, 2023 | 654.00M |
December 31, 2022 | 688.00M |
September 30, 2022 | 695.12M |
June 30, 2022 | 729.39M |
March 31, 2022 | 746.85M |
December 31, 2021 | 750.00M |
September 30, 2021 | 296.68M |
June 30, 2021 | 294.22M |
March 31, 2021 | 270.33M |
Date | Value |
---|---|
December 31, 2020 | 269.99M |
September 30, 2020 | 266.66M |
June 30, 2020 | 52.68M |
March 31, 2020 | 35.51M |
December 31, 2019 | 39.27M |
September 30, 2019 | 39.73M |
June 30, 2019 | 42.33M |
March 31, 2019 | 36.96M |
December 31, 2018 | 39.98M |
September 30, 2018 | 41.60M |
June 30, 2018 | 39.29M |
March 31, 2018 | 38.81M |
December 31, 2017 | 36.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
35.51M
Minimum
Mar 2020
750.00M
Maximum
Dec 2021
420.74M
Average
441.34M
Median
Total Liabilities (Quarterly) Benchmarks
Gilead Sciences Inc | 38.84B |
Catalyst Pharmaceuticals Inc | 85.26M |
Integra Lifesciences Holdings Corp | 2.480B |
Vertex Pharmaceuticals Inc | 5.371B |
Adverum Biotechnologies Inc | 85.54M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.293B |
Shareholders Equity (Quarterly) | 707.00M |
Current Ratio | 5.216 |